NEU 2.99% $20.10 neuren pharmaceuticals limited

Share Price, page-10084

  1. 872 Posts.
    lightbulb Created with Sketch. 72
    Trying to get a handle on the potential value of the upcoming phase 2 NNZ 2591 results...

    If NEU get the $250 mil USD millstone this year ($77 million AUD) and another $65 million in royalty, the cash balance would be about $350 million at the end of the year.

    If the Daybue royalty levels off at $80 million PA leaving a NPAT of say $50 million, and assuming a PE of 16 ($800 million), and the cash, would give a market cap of $1.1 billion....

    Current market cap is $2.4 billion, implying the market is valuing the other trials at $1.3 billion dollars.

    If half of this $1.3 billion is attributed to the upcoming phase 2 results, then could see a $650 million or 25% come off the market cap/share price if results disappoint...

    It will be interesting to see how the market reacts if the results are OK...so neither an obvious failure or success, which I think is most likely.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.